| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/19/2006 | US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same |
| 10/19/2006 | US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators |
| 10/19/2006 | US20060235014 Inhibitors of p38 |
| 10/19/2006 | US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/19/2006 | US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 10/19/2006 | US20060235002 Novel physiologically active substance |
| 10/19/2006 | US20060234231 Microarrays displaying encoded molecules |
| 10/19/2006 | US20060234143 Combining a substituted or unsubstituted indoline with a substituted or unsubstituted 3',6-dichlorofluoran;isolating substituted or unsubstituted 3'-chloro-6'-indolinofluoran combining substituted with a substituted or unsubstituted aniline |
| 10/19/2006 | DE102005017301A1 Substituierte Chromanderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted chroman derivatives, processes for their preparation and their use as anti-inflammatories |
| 10/19/2006 | CA2604836A1 Pyrimidine derivatives and their use in the treatment of cancer |
| 10/19/2006 | CA2604356A1 Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl derivatives and their use as potassium channel blockers |
| 10/19/2006 | CA2603860A1 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates |
| 10/19/2006 | CA2603637A1 Dna-pk inhibitors |
| 10/19/2006 | CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 10/18/2006 | EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors |
| 10/18/2006 | EP1712549A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 10/18/2006 | EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 10/18/2006 | EP1712547A1 Bicycloester derivative |
| 10/18/2006 | EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
| 10/18/2006 | EP1711490A1 Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same |
| 10/18/2006 | EP1711489A1 Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 10/18/2006 | EP1711487A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/18/2006 | EP1711485A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 10/18/2006 | EP1711475A1 2-(phenylamino)-pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders. |
| 10/18/2006 | EP1711181A1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 10/18/2006 | EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 10/18/2006 | EP1534255A4 Processes for preparing 1,3-dioxolane nucleosides |
| 10/18/2006 | EP1260510B1 Fluorescent probes for the quantitation of zinc |
| 10/18/2006 | CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds |
| 10/18/2006 | CN1849308A Thiophenylaminoimidazolines |
| 10/18/2006 | CN1849307A Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 10/18/2006 | CN1849306A Matrix metalloproteinase inhibitors |
| 10/18/2006 | CN1849121A Piperazine derivatives as bradyknin antagonist |
| 10/18/2006 | CN1849117A Entry inhibitors of the HIV virus |
| 10/18/2006 | CN1847322A Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate |
| 10/18/2006 | CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists |
| 10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
| 10/18/2006 | CN1280269C Aliphatic nitrogenous five-membered ring compounds |
| 10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
| 10/18/2006 | CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 10/18/2006 | CN1279818C Herbicidal synergistic composition, and method of controlling weeds |
| 10/17/2006 | US7122693 Acetaldehyde acetal compounds, their synthesis, and uses thereof |
| 10/17/2006 | US7122680 3-Substituted oxindole β3 agonsists |
| 10/17/2006 | US7122675 Gamma secretase inhibitors |
| 10/17/2006 | US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer |
| 10/17/2006 | US7122556 Phenylalanine enamide derivatives |
| 10/17/2006 | US7122550 Protein kinase inhibitors |
| 10/17/2006 | US7122547 Anthranilic acid amides and the use thereof as medicaments |
| 10/17/2006 | US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 10/17/2006 | US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 10/17/2006 | US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS |
| 10/17/2006 | US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 10/17/2006 | US7122377 Bind covalently with the peptides which they are used to tag, permitting the tagged peptides to be subjected to more rigorous washing techniques, tagged peptides are more readily purified, without nonspecifically bound species |
| 10/17/2006 | US7121707 Illuminated electrical cords and outlets |
| 10/17/2006 | CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use |
| 10/17/2006 | CA2260065C Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 10/17/2006 | CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists |
| 10/17/2006 | CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 10/17/2006 | CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106721A1 Pyrimidine derivative having tyrosine kinase inhibitory effect |
| 10/12/2006 | WO2006106711A1 Antifungal agent containing pyridine derivative |
| 10/12/2006 | WO2006106416A1 PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN |
| 10/12/2006 | WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/12/2006 | WO2006106052A1 Pyrazoles |
| 10/12/2006 | WO2006105796A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006105795A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2005105753A8 Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 10/12/2006 | WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 10/12/2006 | US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 10/12/2006 | US20060229359 Tocopherol-modified therapeutic drug compounds |
| 10/12/2006 | US20060229342 TNF-a production inhibitors |
| 10/12/2006 | US20060229339 Novel use of substituted aminomethyl chromans |
| 10/12/2006 | US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| 10/12/2006 | US20060229334 Biphenyl derivatives |
| 10/12/2006 | US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 10/12/2006 | US20060229330 4-aminopyrimidine-5-one derivatives |
| 10/12/2006 | US20060229318 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 10/12/2006 | US20060229312 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 10/12/2006 | US20060229310 Antibacterial compounds |
| 10/12/2006 | US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss |
| 10/12/2006 | US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses |
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/11/2006 | EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1710233A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 10/11/2006 | EP1709965A2 Methods of treating cytokine mediate diseases |
| 10/11/2006 | EP1709964A2 A method of cosmetic depigmentation care by applying at least one aurone |
| 10/11/2006 | EP1709037A2 Hiv protease inhibiting sulfonamides |
| 10/11/2006 | EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 10/11/2006 | EP1709027A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 10/11/2006 | EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 10/11/2006 | EP1709007A1 N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors |
| 10/11/2006 | EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 10/11/2006 | EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 10/11/2006 | EP1708703A2 Chemokine receptor binding compounds |
| 10/11/2006 | EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 10/11/2006 | EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists |